In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best booming stocks to invest in now. The U.S. stock market closed on a downbeat ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week data from a mid-stage study of its lead product candidate, efruxifermin ...

Catriona Yale, the Chief Development Officer of $AKRO, sold 14,467 shares of the company on 01-27-2025 for an estimated $809,428. We received data on the trade from a ...